Genmab A Income Statement (2024-2025) | GMAB

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue 603.00M779.00M816.00M923.00M715.00M925.00M1,022.00M1,058.00M
Cost of Revenue 27.00M28.00M40.00M48.00M42.00M57.00M58.00M-157.00M
Gross Profit 576.00M751.00M776.00M875.00M673.00M868.00M964.00M1,215.00M
Operating items
Research & Development -335.00M-361.00M-336.00M2,446.00M-359.00M-364.00M-357.00M1,080.00M
Selling, General & Administrative -125.00M-129.00M-127.00M919.00M-126.00M-144.00M-148.00M418.00M
Restructuring Costs -25.00M-3.00M-4.00M
Other Operating Expenses -27.00M-28.00M-40.00M324.00M-42.00M-57.00M-58.00M157.00M
Operating Expenses -487.00M-543.00M-506.00M3,685.00M-527.00M-565.00M-563.00M1,655.00M
Operating Income 116.00M236.00M310.00M310.00M188.00M360.00M459.00M58.00M
EBIT 116.00M236.00M310.00M310.00M188.00M360.00M459.00M58.00M
Non-operating items
Non Operating Income 133.00M71.00M-57.00M207.00M56.00M63.00M23.00M
Net income details
EBT 249.00M307.00M253.00M517.00M244.00M423.00M482.00M-1149.00M
Profit After Tax 192.00M203.00M186.00M552.00M195.00M336.00M401.00M-932.00M
Income from Continuing Operations 249.00M307.00M253.00M517.00M244.00M423.00M482.00M-1149.00M
Consolidated Net Income 249.00M307.00M253.00M517.00M244.00M423.00M482.00M-1149.00M
Income towards Parent Company 249.00M307.00M253.00M517.00M244.00M423.00M482.00M-1149.00M
Net Income towards Common Stockholders 249.00M307.00M253.00M517.00M244.00M423.00M482.00M-1149.00M
Additional items
EPS (Basic) 14.0450.4127.9929.2879.7449.9432.24-74.13
EPS (Weighted Average and Diluted) 14.1450.7428.1429.4980.0050.0632.35
Shares Outstanding (Weighted Average) 17.74M6.09M9.04M17.66M3.06M8.47M14.95M15.50M
Shares Outstanding (Diluted Average) 17.61M6.05M8.99M17.53M3.05M8.45M14.90M
EBITDA 199.00M173.00M315.00M310.00M208.00M339.00M407.00M-954.00M
Interest Expenses 35.00M-46.00M-101.00M472.00M45.00M-91.00M-37.00M170.00M